New Zealand Online E-cigarette Retailer: Continue Shipping to Australia

Regulations by 2FIRSTS Leona Zhu
Mar.01.2024
New Zealand Online E-cigarette Retailer: Continue Shipping to Australia
New Zealand e-cigarette retailer mocks Australian government e-cigarette reforms, vows to continue shipping despite import ban.

On March 1, the Australian newspaper "The Guardian" reported that a New Zealand online e-cigarette retailer mocked the Albany government (Australian government) for its e-cigarette reforms. The retailer told customers that they have no intention of stopping e-cigarette shipments because of a "bastard in Canberra," likely referring to federal health minister Mark Butler.

 

Starting from March 1st, e-cigarettes cannot be imported into Australia unless importers have licenses and permits. Importers and manufacturers of prescription e-cigarettes also need to notify the Therapeutic Goods Administration (TGA) in Australia that their products meet standards.

 

A notice posted on the website www.vapoureyes.co.nz without a license for Australian customers states: "If you have not received your order by the deadline, please understand: we do not intend to stop just because of one jerk in Canberra.

 

Even after the March 1 deadline, we will continue to ship internationally (including Australia).

 

The salesperson claimed, "After obtaining reliable legal advice, it is clear that the new regulations in Australia do not apply to us here in New Zealand."

 

"If the Australian Border Force (ABF) wants to waste time trying to prevent you from quitting smoking instead of trying to intercept dozens of hard drugs such as heroin, cocaine, and methamphetamine crossing the Australian border... good luck to them."

 

However, a spokesperson from the Ministry of Health stated that the import ban applies regardless of the country of origin.

 

"This includes New Zealand," they said.

 

The Australian Border Force (ABF) and Therapeutic Goods Administration (TGA) are working closely together to prevent illegal e-cigarettes from entering the country and are prepared to take escalated enforcement actions when necessary, such as issuing warning notices or pursuing legal action.

 

The TGA is taking action to stop overseas websites from advertising to Australians.

 

Butler told The Guardian Australia that despite some e-cigarette and tobacco companies attempting to "try every trick in the book to circumvent our world-leading e-cigarette reforms," the TGA has seized over 360,000 e-cigarettes worth nearly $11 million since January 1. He said this is about three times the amount seized in 2023.

 

"I want to honestly tell everyone, we cannot stop every e-cigarette from entering this country, just like we cannot stop every bit of cocaine or other illegal drugs," Butler said.

 

"But we are dealing with a situation where these things are constantly flowing in and being sold to children, through e-cigarette stores located within walking distance of schools, with 90% of these shops being within walking distance of schools. This is not a coincidence, they are doing this because that is their target market. So, we really just need to cut off this supply."

 

The government is set to introduce legislation in the coming weeks to prohibit the domestic manufacture, advertising, supply, and commercial ownership of non-therapeutic and disposable e-cigarettes. If passed, this would result in the closure of physical e-cigarette stores.

 

Professor Becky Freeman, a tobacco control expert at the University of Sydney, says that Australia should be prepared to have similar responses ready for other retailers.

 

She added that e-cigarette vendors appear to change their information based on their agenda.

 

"On one hand, they constantly remind us that they abide by the law, they are responsible, and they intend to do the right thing by standing on the side of helping people quit smoking and doing good deeds. However, they do not respect the laws of the country in which they want to sell their products."

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
Philippine Customs Seizes Illegal Vape Products Worth Up to PHP 1.4 Billion in Navotas Warehouse
Philippine Customs Seizes Illegal Vape Products Worth Up to PHP 1.4 Billion in Navotas Warehouse
The Philippine Bureau of Customs seized illegal vape products worth an estimated PHP 1 billion to PHP 1.4 billion at a warehouse in Navotas City. Customs Commissioner Ariel Nepomuceno said the operation was the agency’s largest crackdown on illegal vape products since 2024.
Mar.23 by 2FIRSTS.ai
Alcohol, tobacco and cannabis use among Spanish students aged 14–18 hits historic lows
Alcohol, tobacco and cannabis use among Spanish students aged 14–18 hits historic lows
Spain’s 2025 Survey on Drug Use in Secondary Education (ESTUDES), presented by the Ministry of Health, reports historic lows in alcohol, tobacco and cannabis consumption among students aged 14 to 18. The survey shows past-30-day drinking fell from 56.6% in 2023 to 51% in 2025, tobacco use from 21.0% to 15.5%, and cannabis use from 15.5% to 11.6%.
Feb.09 by 2FIRSTS.ai
Smoore International Reports 2025 Revenue of RMB 14.256 Billion, Up 20.8%
Smoore International Reports 2025 Revenue of RMB 14.256 Billion, Up 20.8%
On March 17, Smoore International Holdings Limited released its annual results for the year ended December 31, 2025. Revenue reached RMB 14.256 billion, up 20.8% year on year. Gross profit was RMB 4.857 billion, with a gross margin of 34.1%. Profit for the year was RMB 1.062 billion, down 18.5%, while adjusted profit for the year was RMB 1.530 billion, up 1.3%. By segment, revenue from enterprise customers was RMB 11.344 billion and revenue from own-brand business was RMB 2.912 billion.
Mar.18 by 2FIRSTS.ai
Product | Refillable up to 30 mL in total and claimed 60,000 puffs: MASKKING launches open-system UCEE MAX
Product | Refillable up to 30 mL in total and claimed 60,000 puffs: MASKKING launches open-system UCEE MAX
E-cigarette brand MASKKING has recently listed its new UCEE MAX on its official website. According to the website, the device features an open, refillable design with a stated 10 mL e-liquid capacity, supports three refills, and claims a total of 60,000 puffs.
Mar.02 by 2FIRSTS.ai
Fourth Circuit denies rehearing bid over stay allowing Virginia e-cigarette rules to be enforced
Fourth Circuit denies rehearing bid over stay allowing Virginia e-cigarette rules to be enforced
The U.S. Court of Appeals for the Fourth Circuit has declined to grant en banc or other rehearing of its decision to stay an order that had blocked enforcement of certain Virginia e-cigarette regulations. In a brief order filed Tuesday, the court denied a rehearing petition by Nova Distro Inc. and Tobacco Hut and Vape Fairfax Inc., noting that no judge requested a poll on the petition.
Mar.05 by 2FIRSTS.ai